Pamisel, Foreigners Net Sell 461,000 Shares... Stock Price -3.94%

Pamiscell is trading at 23,150 KRW as of 12:31 PM on the 1st, down 3.94% from the previous day. This represents a 21.84% increase compared to April 29. Pamiscell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners are tentatively recorded as net sellers of 461,000 shares. Over the past five days, individual investors have net sold 452,149 shares, while foreigners and institutions have net bought 471,967 shares and 67,979 shares, respectively.

On May 29, Pamiscell was a market topic with the news of the special import approval of the COVID-19 treatment Remdesivir, described as a "bullish" factor.

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.